A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

NCT04777357 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression
Bipolar I Disorder

Interventions

DRUG: Cariprazine
DRUG: Placebo

Sponsor

AbbVie